Kalyan C. Nannuru

1.7k total citations
20 papers, 886 citations indexed

About

Kalyan C. Nannuru is a scholar working on Oncology, Molecular Biology and Rheumatology. According to data from OpenAlex, Kalyan C. Nannuru has authored 20 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Kalyan C. Nannuru's work include Bone health and treatments (9 papers), Bone Metabolism and Diseases (8 papers) and Chemokine receptors and signaling (5 papers). Kalyan C. Nannuru is often cited by papers focused on Bone health and treatments (9 papers), Bone Metabolism and Diseases (8 papers) and Chemokine receptors and signaling (5 papers). Kalyan C. Nannuru collaborates with scholars based in United States, Japan and Italy. Kalyan C. Nannuru's co-authors include Rakesh K. Singh, Michelle L. Varney, Thomas J. Wilson, Mitsuru Futakuchi, Rakesh K. Singh, Anguraj Sadanandam, Bhawna Sharma, Eric G. Marcusson, Dhananjay M. Nawandar and Rakesh Kumar Singh and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kalyan C. Nannuru

20 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kalyan C. Nannuru United States	16	494	376	274	190	95	20	886
Shinobu Iwai Japan	3	504 1.0×	745 2.0×	277 1.0×	356 1.9×	126 1.3×	6	1.3k
Petra Reusch Germany	12	212 0.4×	521 1.4×	177 0.6×	178 0.9×	66 0.7×	16	877
Carolina Zandueta Spain	17	305 0.6×	443 1.2×	119 0.4×	281 1.5×	168 1.8×	25	833
Naiara Perurena United States	10	359 0.7×	337 0.9×	631 2.3×	143 0.8×	153 1.6×	15	1.1k
Sandrine Théoleyre France	16	763 1.5×	901 2.4×	165 0.6×	330 1.7×	208 2.2×	25	1.4k
Behrouz Zand United States	12	350 0.7×	364 1.0×	204 0.7×	143 0.8×	86 0.9×	34	869
Kyla Driscoll United States	8	618 1.3×	453 1.2×	315 1.1×	172 0.9×	117 1.2×	17	994
P Ardouin France	13	277 0.6×	268 0.7×	341 1.2×	112 0.6×	85 0.9×	19	799
Beáta Somlai Hungary	14	568 1.1×	289 0.8×	567 2.1×	94 0.5×	52 0.5×	29	934
Surabhi Dangi‐Garimella United States	14	673 1.4×	749 2.0×	200 0.7×	426 2.2×	82 0.9×	34	1.4k

Countries citing papers authored by Kalyan C. Nannuru

Since Specialization

Citations

This map shows the geographic impact of Kalyan C. Nannuru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalyan C. Nannuru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalyan C. Nannuru more than expected).

Fields of papers citing papers by Kalyan C. Nannuru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalyan C. Nannuru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalyan C. Nannuru. The network helps show where Kalyan C. Nannuru may publish in the future.

Co-authorship network of co-authors of Kalyan C. Nannuru

This figure shows the co-authorship network connecting the top 25 collaborators of Kalyan C. Nannuru. A scholar is included among the top collaborators of Kalyan C. Nannuru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalyan C. Nannuru. Kalyan C. Nannuru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Nanditha, Xiaoli Zhang, Nyanza J. Rothman, et al.. (2023). Skeletal phenotype amelioration in mucopolysaccharidosis VI requires intervention at the earliest stages of postnatal development. JCI Insight. 8(21). 6 indexed citations

Hwang, Charles, Chase A. Pagani, Nanditha Das, et al.. (2020). Activin A does not drive post-traumatic heterotopic ossification. Bone. 138. 115473–115473. 22 indexed citations

Aykul, Senem, Richard A. Corpina, Erich J. Goebel, et al.. (2020). Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop. eLife. 9. 48 indexed citations

Sharma, Bhawna, Kalyan C. Nannuru, Sugandha Saxena, Michelle L. Varney, & Rakesh K. Singh. (2019). CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis. International Journal of Molecular Sciences. 20(5). 1237–1237. 17 indexed citations

Huang, Lily, Lili Wang, Joyce McClain, et al.. (2019). An Acvr1[R258G] conditional on' mouse model of atypical fibrodysplasia ossificans progressiva (FOP) is Activin A dependent. Bone Abstracts. 1 indexed citations

Das, Nanditha, Sarah Hatsell, Kalyan C. Nannuru, et al.. (2016). In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse Model. PLoS ONE. 11(2). e0150085–e0150085. 23 indexed citations

Sharma, Bhawna, Kalyan C. Nannuru, Michelle L. Varney, & Rakesh K. Singh. (2014). Host Cxcr2-dependent regulation of mammary tumor growth and metastasis. Clinical & Experimental Metastasis. 32(1). 65–72. 37 indexed citations

Sharma, Bhawna, Dhananjay M. Nawandar, Kalyan C. Nannuru, Michelle L. Varney, & Rakesh K. Singh. (2013). Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis. Molecular Cancer Therapeutics. 12(5). 799–808. 100 indexed citations

Nannuru, Kalyan C., Mitsuru Futakuchi, Michelle L. Varney, et al.. (2010). Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface. Cancer Research. 70(9). 3494–3504. 107 indexed citations

10.

Nannuru, Kalyan C. & Rakesh K. Singh. (2010). Tumor-Stromal Interactions in Bone Metastasis. Current Osteoporosis Reports. 8(2). 105–113. 30 indexed citations

11.

Sharma, Bhawna, Dhananjay M. Nawandar, Michelle L. Varney, Kalyan C. Nannuru, & Rakesh K. Singh. (2010). Abstract 5462: Enhancing efficacy of drugs by targeting CXCR2 receptor signaling for the treatment of malignant breast cancer. Cancer Research. 70(8_Supplement). 5462–5462. 1 indexed citations

12.

Wilson, Thomas J., Kalyan C. Nannuru, Mitsuru Futakuchi, & Rakesh K. Singh. (2009). Cathepsin G-mediated enhanced TGF-β signaling promotes angiogenesis via upregulation of VEGF and MCP-1. Cancer Letters. 288(2). 162–169. 63 indexed citations

13.

Nannuru, Kalyan C., Mitsuru Futakuchi, Anguraj Sadanandam, et al.. (2009). Enhanced expression and shedding of receptor activator of NF-κB ligand during tumor–bone interaction potentiates mammary tumor-induced osteolysis. Clinical & Experimental Metastasis. 26(7). 797–808. 15 indexed citations

14.

Singh, Seema, Anguraj Sadanandam, Michelle L. Varney, Kalyan C. Nannuru, & Rakesh K. Singh. (2009). Small interfering RNA‐mediated CXCR1 or CXCR2 knock‐down inhibits melanoma tumor growth and invasion. International Journal of Cancer. 126(2). 328–336. 49 indexed citations

15.

Wilson, Thomas J., Kalyan C. Nannuru, & Rakesh K. Singh. (2009). Cathepsin G Recruits Osteoclast Precursors via Proteolytic Activation of Protease-Activated Receptor-1. Cancer Research. 69(7). 3188–3195. 44 indexed citations

16.

Singh, Seema, Anguraj Sadanandam, Kalyan C. Nannuru, et al.. (2009). Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis. Clinical Cancer Research. 15(7). 2380–2386. 125 indexed citations

17.

Wilson, Thomas J., Kalyan C. Nannuru, & Rakesh Kumar Singh. (2009). Cathepsin G–Mediated Activation of Pro–Matrix Metalloproteinase 9 at the Tumor-Bone Interface Promotes Transforming Growth Factor-β Signaling and Bone Destruction. Molecular Cancer Research. 7(8). 1224–1233. 60 indexed citations

18.

Wilson, Thomas J., Kalyan C. Nannuru, Mitsuru Futakuchi, Anguraj Sadanandam, & Rakesh K. Singh. (2008). Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κB Ligand. Cancer Research. 68(14). 5803–5811. 82 indexed citations

19.

Futakuchi, Mitsuru, Kalyan C. Nannuru, Michelle L. Varney, et al.. (2008). Transforming growth factor‐β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation. Cancer Science. 100(1). 71–81. 54 indexed citations

20.

Nannuru, Kalyan C., Mitsuru Futakuchi, Thomas J. Wilson, et al.. (2007). Up-regulation of soluble RANKL at tumor-bone interface is critical for mammary tumor-induced osteolysis. Cancer Research. 67. 2795–2795. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact